Description: Theravance Biopharma, Inc. operates as a biopharmaceutical company. It provides discovery, development, and commercialization of small molecule medicines primarily for therapeutic areas of respiratory diseases, bacterial infections, and central nervous system (CNS)/pain. The company is based in George Town, Cayman Islands. Theravance Biopharma, Inc. operates as a subsidiary of Theravance Inc.
Home Page: www.theravance.com
TBPH Technical Analysis
Ugland House
George Town,
KY1-1104
Cayman Islands
Phone:
650 808 6000
Officers
| Name | Title |
|---|---|
| Mr. Rick E. Winningham M.B.A. | Chairman & CEO |
| Mr. Andrew Asa Hindman M.B.A | Sr. VP & CFO |
| Ms. Rhonda F. Farnum | Chief Bus. Officer and Sr. VP of Commercial & Medical Affairs |
| Dr. Richard A. Graham Ph.D. | Sr. VP of R&D |
| Ms. Gail B. Cohen | VP of Corp. Communications & Investor Relations |
| Mr. Brett A. Grimaud Esq. | Sr. VP, Gen. Counsel & Sec. |
| Ms. Stacy L. Pryce | Sr. VP & Chief Strategy Officer |
Exchange: NASDAQ
Country: US : United States of America
Currency: US Dollar ($)
| GIC Sector: | Health Care |
|---|---|
| GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
| GIC Industry: | Pharmaceuticals |
| GIC Sub-Industry: | Pharmaceuticals |
| Forward PE: | 7.1839 |
|---|---|
| Trailing PE: | 0 |
| Price-to-Book MRQ: | 1.5714 |
| Price-to-Sales TTM: | 14.1142 |
| IPO Date: | 2014-05-16 |
| Fiscal Year End: | December |
| Full Time Employees: | 158 |